Pfizer Challenges uniQure Patents at the PTAB
shot by IP News Shots / 7:30 pm on 12 May, 2021
Pfizer Inc. has challenged two patents belonging to uniQure N.V. at the Patent Trial and Appeal Board (PTAB). Pfizer has asserted that the two hemophilia patents that they have challenged do not contain any new idea and need to be invalidated.
Read More at: https://news.bloomberglaw.com/ip-law/pfizer-files-ipr-challenge-to-uniqure-hemophilia-patents
Industry: Biotechnology, Pharmaceuticals
CAFC Affirms PacBio’s Patent Dispute Loss
shot by IP News Shots / 7:29 pm on 12 May, 2021
The US Court of Appeals for the Federal Circuit (CAFC) has affirmed a patent invalidity ruling by the US District Court for the District of Delaware against Pacific Biosciences of California Inc. (PacBio) The lower court had found that the DNA sequencing patents, that PacBio has accused Oxford Nanopore Technologies Inc. of infringing upon, were invalid based on lack of enablement. The CAFC judge agreed with the reasoning provided by the lower court for the invalidity of the two patents.
Read More at: https://www.reuters.com/article/us-ip-pacbio-patents-idUSKBN2CS2TP
Industry: Biotechnology
Laevoroc Acquires Patents for Oral Gemcitabine Prodrug
shot by IP News Shots / 7:16 pm on 12 May, 2021
Laevoroc Oncology AG has announced the acquisition of worldwide patents for oral gemcitabine prodrug, an important chemotherapy agent. The acquisition which provides Laevoroc with worldwide rights except in China, will help them bring revolutionary therapies for cancer patients.
Industry: Biotechnology, Pharmaceuticals
Natera Accused of Infringing on DNA Sequencing Assembly Patent
shot by IP News Shots / 10:38 am on 12 May, 2021
Invitae Corp. has accused Natera Inc. of patent infringement with their Signatera cancer diagnostic test and a lawsuit in the same regard has been filed with the US District Court for the District of Delaware. The plaintiff, Invitae, alleges that the defendant is infringing its patented techniques for assembling DNA sequencing reads.
Industry: Biotechnology
10x Genomics Goes to Court with Patent Infringement Complaint against NanoString
shot by IP News Shots / 7:37 pm on 07 May, 2021
10x Genomics Inc. has moved to court with a complaint of alleged patent infringement by NanoString Technologies Inc. 10x has asserted in their complaint with the US District Court for the District of Delaware that the defendant infringes on five of their RNA analysis patents with its GeoMx Digital Spatial Profiler.
Read More at: https://www.reuters.com/business/legal/brief-10x-genomics-sues-nanostring-over-rna-analysis-patents-2021-05-06/
Industry: Biotechnology
Legal Action in Patent Dispute against Pfizer and BioNTech to Stay
shot by IP News Shots / 7:02 pm on 06 May, 2021
The US District Court for the Southern District of California has rejected an appeal by Pfizer Inc. and BioNTech SE to dismiss a patent case brought by Allele Biotechnology and Pharmaceuticals Inc. The pharma companies had urged the court to dismiss the case under the safe harbour provision of the Hatch-Waxman Act but the court found that the patent-protected protein belonging to Allele cannot be covered under the provision.
Read More at: https://www.law360.com/california/articles/1381605/pfizer-loses-bid-to-toss-covid-19-vaccine-ip-case-
Industry: Biotechnology, Pharmaceuticals